These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17205947

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed].
    Schrama E, Eusman JP.
    Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2672; author reply 2672-3. PubMed ID: 17205946
    [No Abstract] [Full Text] [Related]

  • 3. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)].
    Diener HC.
    MMW Fortschr Med; 2004 Jun 10; 146(24):50. PubMed ID: 15366496
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
    Almdal TP, Eldrup E, Godtfredsen J, Kofoed-Enevoldsen A.
    Ugeskr Laeger; 1999 Aug 23; 161(34):4771-2. PubMed ID: 10500471
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Secondary prevention after stroke. 2 platelet inhibitors are better than one].
    MMW Fortschr Med; 2002 May 09; 144(19):61. PubMed ID: 12116558
    [No Abstract] [Full Text] [Related]

  • 10. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
    Biller J.
    J Neurol Sci; 2009 Sep 15; 284(1-2):1-9. PubMed ID: 19380153
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use.
    Moonis M, Fisher M.
    Expert Rev Cardiovasc Ther; 2003 Nov 15; 1(4):611-5. PubMed ID: 15030260
    [No Abstract] [Full Text] [Related]

  • 15. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1453-62. PubMed ID: 17559741
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
    Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A.
    J Neurol Sci; 1996 Nov 15; 143(1-2):1-13. PubMed ID: 8981292
    [Abstract] [Full Text] [Related]

  • 18. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP, Lodder J.
    Expert Rev Neurother; 2008 Nov 15; 8(11):1661-5. PubMed ID: 18986236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
    Gibbs CR, Li-Saw-Hee FL, Lip GY.
    Scott Med J; 1998 Feb 15; 43(1):6. PubMed ID: 9533251
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.